![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
TRIBE-2: FOLFOX or FOLFIRI With Bevacizumab in mCRC (OncLive) View |
![]() |
TRIBE2: Latest data for patients with mCRC (ecancer) View |
![]() |
FIRE-4.5: FOLFOXIRI plus either bevacizumab or cetuximab in mCRC (VJOncology) View |
![]() |
Debate 2: BRAF mutant mCRC patients - FOLFIRINOX/Bev (HMP Education) View |
![]() |
Debate: Borderline resectable liver metastasis in RAS WT CRC - FOLFOX (or FOLFOXIRI)/Bev (HMP Education) View |
![]() |
Choosing Between Anti-VEGF and Anti-EGFR Targeted Therapy (OncLive) View |
![]() |
Bevacizumab and cetuximab (plus chemotherapy) equally effective for colorectal cancer patients (ecancer) View |
![]() |
Bevacizumab and colorectal cancer in geriatrics (ecancer) View |
![]() |
GI chemotherapy education – side effects: Folfiri (MD Anderson Cancer Center) View |
![]() |
FOLFIRI side effects (Shannon Warr) View |